We undertook a pan‐cancer analysis of CIA‐II in 33 cancer types and detected that higher CIA‐II expression was tightly linked to poorer prognosis, higher ICPGs expression, and higher TMB in pan‐LGG. This evidence concerns the gene ASF1B and cancer.